BALANCE SHEETS - USD ($)	Mar. 31, 2017	Sep. 30, 2016
CURRENT ASSETS:
Cash and cash equivalents	$ 1,529,802	$ 2,917,996
Receivables	4,252	394,515
Prepaid expenses	720,466	981,677
Deposits - current portion	150,000	154,995
Inventory used for R&D and manufacturing	678,664	1,008,642
Deferred rent - current portion	400,039	429,821
Total current assets	3,483,223	5,887,646
RESEARCH AND OFFICE EQUIPMENT, net	219,337	226,216
PATENT COSTS, net	239,214	256,547
DEFERRED RENT - net of current portion	3,113,148	3,406,921
DEPOSITS	1,670,917	1,820,917
TOTAL ASSETS	8,725,839	11,598,247
CURRENT LIABILITIES:
Accounts payable	7,074,898	3,091,512
Accrued expenses	509,841	378,672
Due to employees	607,289	538,278
Derivative instruments, current portion	208,493	0
Other current liabilities	7,792	3,310
Total current liabilities	8,408,313	4,011,772
Derivative instruments - net of current portion	3,228,252	8,394,934
Deferred revenue	125,000	125,000
Other liabilities	40,478	22,609
Total liabilities	11,802,043	12,554,315
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Preferred stock, $.01 par value--200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 216,478,331 and 155,962,079 shares issued and outstanding at March 31, 2017 and September 30, 2016, respectively	2,164,784	1,559,621
Additional paid-in capital	285,299,676	283,152,288
Accumulated deficit	(290,540,664)	(285,667,977)
Total stockholders' deficit	(3,076,204)	(956,068)
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	$ 8,725,839	$ 11,598,247